Literature DB >> 3064356

Luminography--an alternative assay for detection of von Willebrand factor multimers.

R Schneppenheim1, H Plendl, U Budde.   

Abstract

A luminescence assay was adapted for detection of von Willebrand factor multimers subsequent to SDS-agarose gel electrophoresis and electroblotting onto nitrocellulose. The method is as fast as chromogenic detection methods and appears to be as sensitive as autoradiography without the disadvantages of the latter.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3064356

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  14 in total

1.  Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

Authors:  Svenja Lippok; Matthias Radtke; Tobias Obser; Lars Kleemeier; Reinhard Schneppenheim; Ulrich Budde; Roland R Netz; Joachim O Rädler
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

2.  The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.

Authors:  Sandra L Haberichter; Ulrich Budde; Tobias Obser; Sonja Schneppenheim; Cornelia Wermes; Reinhard Schneppenheim
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

3.  Mutation G1629E Increases von Willebrand Factor Cleavage via a Cooperative Destabilization Mechanism.

Authors:  Camilo Aponte-Santamaría; Svenja Lippok; Judith J Mittag; Tobias Obser; Reinhard Schneppenheim; Carsten Baldauf; Frauke Gräter; Ulrich Budde; Joachim O Rädler
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

4.  Exponential size distribution of von Willebrand factor.

Authors:  Svenja Lippok; Tobias Obser; Jochen P Müller; Valentin K Stierle; Martin Benoit; Ulrich Budde; Reinhard Schneppenheim; Joachim O Rädler
Journal:  Biophys J       Date:  2013-09-03       Impact factor: 4.033

5.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Analysis of von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit.

Authors:  A M Cumming; R T Wensley
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

7.  Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.

Authors:  K A Cooney; S E Lyons; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

Authors:  Sandra L Haberichter; Giancarlo Castaman; Ulrich Budde; Ian Peake; Anne Goodeve; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jorgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank G H Hill; Robert R Montgomery
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

9.  Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.

Authors:  T Obser; M Ledford-Kraemer; F Oyen; M A Brehm; C V Denis; R Marschalek; R R Montgomery; J E Sadler; S Schneppenheim; U Budde; R Schneppenheim
Journal:  J Thromb Haemost       Date:  2016-08-20       Impact factor: 5.824

10.  Genetic heterogeneity of severe von Willebrand disease type III in the German population.

Authors:  R Schneppenheim; S Krey; F Bergmann; D Bock; U Budde; M Lange; R Linde; U Mittler; E Meili; G Mertes
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.